AACR Presentations to Feature ATNM-400 and Actimab-A Programs Across Solid Tumors and Hematologic Oncology Applications NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a pioneer in the development of...
Hence then, the article about actinium pharmaceuticals inc to present two abstracts at the 2026 aacr annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting )
Also on site :
- Iranian Foreign Minister spokesperson in exclusive interview discusses cause of the war and Iran’s stance
- Walmart’s 'Very Sturdy' $53 3-Piece Patio Set Is Perfect for Small-Space Entertaining
- ‘Inflationary surge’: Fed economists warn AI hype is overheating the economy whether or not the technology ever delivers